Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $596.3300 (3.92%) ($573.4200 - $596.3300) on Wed. Sep. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.98% (three month average) | RSI | 32 | Latest Price | $596.3300(3.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(36%) IWD(33%) SPLV(33%) SPY(31%) | Factors Impacting REGN price | REGN will decline at least -0.99% in a week (0% probabilities). TBT(-8%) VIXM(-6%) UUP(-5%) VXX(-1%) SHY(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.99% (StdDev 1.98%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $608.61 | 5 Day Moving Average | $586.54(1.67%) | 10 Day Moving Average | $591.4(0.83%) | 20 Day Moving Average | $608.61(-2.02%) | To recent high | -8.1% | To recent low | 8.9% | Market Cap | $63.228b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |